REQUEST A CONSULTATION

View Actual Treatment Videos
A new patented scientific discovery by the INR, as documented in the videos above, now promises to change current thinking about the potential for recovery after stroke or brain injury, even years later.

Complete the form below to receive, by e-mail, two detailed scientific publications and to request a consultation.

Asterisk (*) denotes a Required Field.

Medical History Information

Name*

FirstLast

Location

State / Province / RegionCountry

Email*

Phone

Where did you hear about us?*

Patient Information

What is the age of the patient?*

Has the patient been diagnosed with:*

Stroke

Traumatic Brain Injury

Other, please specify diagnosis below:

Check all that apply.

Please specify diagnosis:

Year of Occurence*

Can the patient walk?*

Yes

With Assistance, Cane, or Walker

No

Talking Status*

Additional Information

CAPTCHA

Phone

This field is for validation purposes and should be left unchanged.

About the Institute

In 2003 the INR published the first of its many peer-reviewed scientific publications documenting the INR's medical breakthroughs in the field of neuroinflammation. Since that time scientists around the world have developed supporting evidence that suggests, in accordance with the findings of INR physicians, that dormant circuits in the brain and other parts of the central nervous system, following stroke and other forms of injury, are capable of being re-activated, resulting in rapid neurological improvement. The INR's breakthrough treatment is not experimental: it has been used for thousands of patients from every populated continent in the world.

Hundreds of scientific articles from academic scientists have cited INR publications. In addition to patient care, the INR trains physicians in the proper implementation of its patented, off-label treatment methods. The INR Physician Training Program has been attended by physicians from six continents.

The INR's issued and pending U.S. and foreign patents, include, but are not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8,900,583; Australian patents 758523 and 2011323616 B2, Canadian patent 2,811,948, European patent ES2620749 (T3), etc., all assigned to TACT IP LLC.